Neuland Ranked as a top regulatory performer in survey of customers and industry leaders

For over 25 years Neuland Labs has been at the forefront of manufacturing APIs through its cGMP manufacturing facilities, working with customers in 85 countries, Neuland Labs has developed more than 300 processes and 60 APIs, and it has filed more than

infrastructure-img-new

Neuland Laboratories Ltd, a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and contract manufacturing services to customer located in 85 countries, announced it has been awarded a 2013 CMO Leadership award from Life Science leader magazine in the regulatory category, which complements the company's long track record of current Good Manufacturing Practices (cGMP) excellence.

In accepting the 2013 award, Neuland's Chief Executive Officer, Mr. Sucheth R. Davuluri, commented, "Creating a quality-conscious organization has been a goal from our founding days, and we are proud that in our almost 30 years as an API and contract pharmaceutical manufacturer, we have compiled a consistent track record of cGMP excellence. We are honored that our strengths in regulatory reporting and processing have been recognized with a CMO Leadership Award from our customers and other industry leaders, as we strive to extend this record of comprehensive regulatory excellence."

Neuland provides products and services to customers in 85 countries focusing on the US, Europe and Japan. It is inspected and certified by the most rigorous regulatory agencies in the world. Consistent with its record of cGMP excellence, Neuland's lst two FDA inspections had no Form 483 citation issued.
Mr. Davuluri continued, "We intend to continue the high level of vigilance and oversight in every aspect of our operations that has enabled us to maintain this consistent record of quality and reliability, and we want to acknowledge the exceptional team at the Neuland who made this award possible, with their ongoing daily commitment to quality in everything that we do."

The CMO Leadership Awards are based on responses of more than 10,000 pharmaceutical and biopharmaceutical executives to a survey conducted by nice Insight and sponsored by Life Science Leader magazine. the award recognizes those contract manufacturing organization that are the most highly rated by industry respondents. The survey covered more than 100 CMOs.
The 2013 CMO leadership Awards will be formally presented at a ceremony in New York City on March 12, 2014.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X